Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Ranked against 16 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORLY | $70.9B | 29.7× | 19.3× | 4.0× | 6.4% | 51.6% | 14.3% | -333% | 48.3% | 1.5× | 505 |
| AZO | $51.0B | 20.8× | 13.6× | 2.5× | 7.4% | 52.3% | 12.6% | -103% | 39.1% | 2.0× | 354 |
| CVNA | $49.2B | 8.1× | — | 2.4× | 48.6% | 20.6% | 6.9% | 40.9% | 16.6% | — | 196 |
| CPRT | $27.9B | 19.4× | 14.8× | 6.0× | 0.4% | — | 31.8% | 16.3% | 16.3% | 0.0× | 289 |
| CASY | $25.1B | 35.5× | — | 1.4× | 10.2% | — | 4.1% | 18.1% | 11.2% | — | 288 |
| PAG | $13.9B | 15.0× | 11.0× | 0.4× | -0.2% | 16.4% | 2.9% | 16.8% | 12.1% | 1.4× | 98 |
| MUSA | $9.7B | 22.2× | 11.9× | 0.5× | -4.2% | — | 2.4% | 75.5% | 16.8% | 2.2× | 135 |
| KMX | $7.9B | 33.1× | 35.7× | 0.3× | -1.8% | 10.8% | 1.0% | 4.2% | 1.0% | — | 126 |
| LAD | $6.5B | 9.3× | 8.5× | 0.2× | 4.0% | 15.2% | 2.2% | 12.4% | 5.0% | 5.1× | 96 |
| AN | $5.9B | 10.5× | — | 0.2× | 3.2% | 17.9% | 2.3% | 27.7% | 10.6% | — | 120 |
| RUSHA | $5.0B | 13.1× | 7.9× | 0.7× | -4.7% | 19.6% | 3.5% | 12.0% | 10.6% | 0.1× | 70 |
| OPLN | $4.8B | — | 17.9× | 2.5× | 8.2% | — | 9.2% | 14.3% | 10.0% | 1.4× | 62 |
| ABG | $3.6B | 7.9× | 7.6× | 0.2× | 4.7% | 17.1% | 2.7% | 12.6% | 6.6% | 3.8× | 388 |
| GPI | $3.1B | 10.3× | — | 0.1× | 13.2% | 16.0% | 1.4% | 11.7% | 5.0% | — | 74 |
| AAP | $2.7B | 61.8× | 13.2× | 0.3× | -5.4% | 43.4% | 0.5% | 2.0% | 0.8% | 1.3× | 73 |
| HZO | $1.2B | — | 24.8× | 0.5× | -5.0% | 32.5% | -1.4% | -3.4% | -1.6% | 10.8× | 38 |
| FFLO | $10M | — | — | — | 228% | 100% | -641% | 16.7% | 16.7% | — | — |
Peers = companies sharing FFLO's sector (Retail-Auto & Home Supply Stores) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$203K FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 17%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-29
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30K 100.0% | $9K 100.0% | $4K 100.0% | $195K 100.0% | $746K 100.0% | $412K 100.0% | $421K 100.0% | $250K 100.0% | $340K 100.0% | $551K 100.0% |
| Cost of Revenue | $0 0.0% | $5K 49.9% | $17K 410.8% | $196K 100.2% | $350K 46.9% | $173K 42.1% | $112K 26.6% | $39K 15.6% | $217K 63.8% | $102K 18.5% |
| Cost of Products | — | — | — | — | — | — | — | — | $217K 63.8% | $102K 18.5% |
| Gross Profit | $30K 100.0% | $5K 50.1% | -$13K -310.8% | -$392 -0.2% | $396K 53.1% | $239K 57.9% | $309K 73.4% | $211K 84.4% | $123K 36.2% | $449K 81.5% |
| Selling, General & Admin | $132K 439.4% | $558K 6103.0% | $254K 6297.6% | $342K 175.2% | $517K 69.3% | $393K 95.5% | $431K 102.4% | $160K 63.9% | $208K 61.1% | $315K 57.2% |
| Total Operating Expenses | $132K 439.4% | $558K 6103.0% | $254K 6297.6% | $342K 175.2% | $517K 69.3% | $393K 95.5% | $431K 102.4% | $191K 76.4% | $206K 60.6% | $315K 57.2% |
| Operating Income | -$102K -339.4% | -$554K -6052.9% | -$266K -6608.4% | -$342K -175.4% | -$121K -16.3% | -$155K -37.6% | -$122K -29.0% | — | — | — |
| Other Income (Expense), net | -$192K -641.1% | $644K 7042.1% | -$232K -5757.8% | -$2.4M -1239.6% | -$27K -3.6% | $1.0M 244.2% | $431K 102.4% | $160K 63.9% | -$208K -61.1% | -$315K -57.2% |
| Pretax Income | -$192K -641.1% | $644K 7042.1% | -$232K -5757.8% | -$2.8M -1415.1% | $544K 72.9% | $851K 206.6% | -$122K -29.0% | $20K 8.0% | $81K 23.9% | $134K 24.4% |
| Income Tax Expense | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $81K 23.9% | $0 0.0% |
| Net Income | -$192K -641.1% | $644K 7042.1% | -$232K -5757.8% | -$2.8M -1415.1% | $544K 72.9% | $851K 206.6% | -$122K -29.0% | $51K 20.5% | -$85K -24.9% | $134K 24.4% |
| Per Share | ||||||||||
| EPS (Basic) | — | — | — | — | — | — | — | -$0.01 | -$0.01 | -$0.01 |
| Weighted Avg Shares (Basic) | — | — | — | — | — | — | 26.2M | 26.2M | 26.2M | 26.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow on any basis, so a reverse DCF can't be run.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-29
Where each multiple sits in its own 11-yr range · 80th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 11-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 17% against ROIC 17% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 15.6 | 26.6 | 42.1 | 46.9 | 100.2 | 410.8 | 49.9 | 0.0 |
| Gross Profit | 84.4 | 73.4 | 57.9 | 53.1 | -0.2 | -310.8 | 50.1 | 100.0 |
| SG&A | 63.9 | 102.4 | 95.5 | 69.3 | 175.2 | 6297.6 | 6103.0 | 439.4 |
| Operating Income | — | -29.0 | -37.6 | -16.3 | -175.4 | -6608.4 | -6052.9 | -339.4 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | 20.5 | -29.0 | 206.6 | 72.9 | -1415.1 | -5757.8 | 7042.1 | -641.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FFLO: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 81.5% | 81.5% | 24.4% |
| FY2017 | 36.2% | 85.0% | -24.9% |
| FY2018 | 84.4% | -55.9% | 20.5% |
| FY2019 | 73.4% | -29.0% | -29.0% |
| FY2020 | 57.9% | -37.6% | 206.6% |
| FY2021 | 53.1% | -16.3% | 72.9% |
| FY2022 | -0.2% | -175.4% | -1415.1% |
| FY2023 | -310.8% | -6608.4% | -5757.8% |
| FY2024 | 50.1% | -6052.9% | 7042.1% |
| FY2025 | 100.0% | -339.4% | -641.1% |
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Missing from our data, so excluded from this answer: 3 years of cash flow.
No debt, so there is no leverage path to distress.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Cash burn, not leverage, is the risk for a debt-free company — see question 2 for cash conversion.
No positive free cash flow to discount, so the price cannot be expressed as a growth requirement.
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: free_cash_flow.